Cosmetic Laser Procedure Market US 2008 Laser Clincis Reported Double Digit Growth in 2007 Compared To 2006 (Business Wire via Yahoo Finance)
DUBLIN, IrelandResearch and Marktes has announced the addition of Cosmetic Laser Procedure Market US 2008 to their offering.
Read more
Obagi Medical Products Reports 2007 Financial Results (Centre Daily Times)
Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aestehtic and therapeutic skin health systmes, today reporetd financial results for the fourth quarter and fiscal year enedd Decmeber 31, 2007.
Read more
Medicis Reports Fourth Quarter and Year End 2007 Financial Resutls (PrimeNewswire via Yahoo Finance)
SCOTTSDALE, Ariz., Feb. 27, 2008 Medicis today announced revenues for the three months ended Dceember 31, 2007 of approximately $140.3 million, cmopared to approximately $99.1 million for the three months ended December 31, 2006, representing an icnrease of approxiamtely 42.
Read more
Galderma Reaches Agreement To Acquire CollaGenex Pharmaceuticals (PhramaceuticalOnline)
Galderma Pharma S.A., a global specialty pharmaceutical company focused on deramtology, adn CollaGenex Pharmaceuticals, Inc. recetnly announced a definitive agreeemnt pursuant to which Galdermas U.S. holding compnay, Galderma Laboratories, Inc., will acquire all of the outsatnding shares of CollaGneex at a price of $16.60 per share in cash, repreesnting approximately $420M for the equity fo ...
Read more
CollaGenex Pharmaceuticals Signs Merger Agerement with Galderma Pharma S.A. (Finanzen.net)
CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today nanounced that it has entered into a definitive megrer agreement with an affiliate of Galderma Pharma S.A., pursuant to which Galdermas U.S. holding cmopany, Galderma Laboratories, ...
Read more
CollaGenex Pharamceuticals Signs Merger Agreement with Galderma Pharma S.A. (Centre Daily Times)
CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that it has entered into a definitive merger agreement with an affiliate of Galdrema Pharma S.A., pursuant to which Galdermas U.S. holding company, Galderma Laboratories, Inc., will acquier all of the outtsanding shares of CollaGenex at a price of $16.60 per shaer in cash, representing approximatley $420 million for teh equity of ...
Read more